SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
+4.73%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
(+28%)
Cap. Flow
+$261M
Cap. Flow
% of AUM
17.92%
Top 10 Holdings %
Top 10 Hldgs %
74.27%
Holding
127
New
16
Increased
47
Reduced
20
Closed
15
Top Buys
Top Sells
| 1 |
Simplify High Yield ETF
CDX
|
$63.4M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$28.6M |
| 3 |
Merck
MRK
|
$6.35M |
| 4 |
Boston Scientific
BSX
|
$6.13M |
| 5 |
Novo Nordisk
NVO
|
$5.63M |
Sector Composition
| 1 | Healthcare | 18.32% |
| 2 | Energy | 1.62% |
| 3 | Industrials | 1.53% |
| 4 | Technology | 0.5% |
| 5 | Real Estate | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares Core S&P 500 ETF
IVV
$662B
| $429M | 20% |
744,368
+42,003
| +6% | +$24.2M |
|
|
2
iShares Core US Aggregate Bond ETF
AGG
$131B
| $143M | 6.65% |
1,409,731
-282,860
| -17% | -$28.6M |
|
3
Simplify Aggregate Bond ETF
AGGH
$319M
| $113M | 5.25% |
5,193,254
+296,513
| +6% | +$6.44M |
|
4
Simplify Stable Income ETF
BUCK
$348M
| $109M | 5.09% |
4,448,579
+1,232,481
| +38% | +$30.3M |
|
|
NMB
5
Simplify National Muni Bond ETF
NMB
$46.6M
| $78.8M | 3.67% |
+3,126,710
| New | +$78.8M |
|
6
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
$90.2M
| $55.6M | 2.59% |
3,866,164
+3,839,219
| +14,248% | +$55.2M |
|
7
Simplify MBS ETF
MTBA
$1.43B
| $55.3M | 2.58% |
1,075,137
+190,684
| +22% | +$9.82M |
|
8
Schwab US TIPS ETF
SCHP
$13.9B
| $38.1M | 1.78% |
710,451
+104,765
| +17% | +$5.62M |
|
|
9
Simplify High Yield ETF
CDX
$358M
| $32.6M | 1.52% |
1,374,907
-2,671,090
| -66% | -$63.4M |
|
10
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.8B
| $25.4M | 1.18% |
+251,800
| New | +$25.4M |
|
11
JPMorgan Ultra-Short Income ETF
JPST
$33.1B
| $25M | 1.17% |
+493,580
| New | +$25M |
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $24.1M | 1.12% |
193,010
+88,474
| +85% | +$11M |
|
13
Applied Therapeutics
APLT
$71M
| $23.9M | 1.12% |
2,817,505
| – | – |
|
14
Plains GP Holdings
PAGP
$3.82B
| $23.5M | 1.1% |
1,272,360
-100,000
| -7% | -$1.85M |
|
15
Eli Lilly
LLY
$657B
| $16.9M | 0.79% |
19,082
+7,670
| +67% | +$6.8M |
|
16
PureCycle Technologies
PCT
$2.57B
| $16.8M | 0.78% |
1,772,056
+713,664
| +67% | +$6.78M |
|
17
UnitedHealth
UNH
$281B
| $11.9M | 0.55% |
20,372
+6,772
| +50% | +$3.96M |
|
18
Sanofi
SNY
$121B
| $11.8M | 0.55% |
+204,143
| New | +$11.8M |
|
19
Zoetis
ZTS
$69.3B
| $11.7M | 0.54% |
+59,801
| New | +$11.7M |
|
20
Intuitive Surgical
ISRG
$170B
| $11.4M | 0.53% |
23,230
+7,892
| +51% | +$3.88M |
|
21
Johnson & Johnson
JNJ
$427B
| $11M | 0.51% |
67,601
+44,081
| +187% | +$7.14M |
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.1M | 0.47% |
9,591
+3,231
| +51% | +$3.4M |
|
23
Phathom Pharmaceuticals
PHAT
$864M
| $9.44M | 0.44% |
521,935
| – | – |
|
24
AbbVie
ABBV
$372B
| $9.33M | 0.43% |
+47,252
| New | +$9.33M |
|
25
Thermo Fisher Scientific
TMO
$186B
| $8.52M | 0.4% |
13,770
+5,546
| +67% | +$3.43M |
|